← Back to Clinical Trials
Recruiting NCT07130734

NCT07130734 Digital Intervention for Physical Activity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07130734
Status Recruiting
Phase
Sponsor Auburn University
Condition Depression - Major Depressive Disorder
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-09-22
Primary Completion 2026-05

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Digital Physical Activity

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-09-22 with a primary completion date of 2026-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The present study will assess the effects of a four-week digitally delivered intervention on physical activity and depressive symptoms among adults experiencing at least moderate depressive symptoms. The main questions this research aims to answer are: * Does a digitally-delivered intervention increase physical activity levels? * Does a digitally-delivered intervention reduce symptoms of depression? Researchers will compare an intervention promoting physical activity to a passive control (does not receive the intervention) group to see if the intervention reduces depressive symptoms and increases physical activity levels. Participants will: * Visit the laboratory at two separate time points before group assignment, separated by one week of physical activity monitoring * Be randomly assigned to complete four weeks of a digital intervention prompting engagement in physical activity or have their mental health symptoms monitored over four weeks (i.e., passive control group) * Visit the laboratory at two separate time points after the intervention, separated by one week of physical activity monitoring

Eligibility Criteria

Inclusion Criteria: * Between the ages of 19 and 40 years * Verbally fluent in English (i.e., must be able to speak or understand English) * No uncorrected visual or hearing impairment * Moderate depressive symptoms or greater of at least 10 or higher on the Patient Health Questionnaire-8 screening instrument * Eligible to participate in physical activity * Physically inactive (i.e., engaging in less than 150 min of weekly moderate-to-vigorous physical activity) * Owns an Apple or Android mobile device, willing to download the Pathverse app , and willing to keep the device on during the study period * Not currently pregnant Exclusion Criteria: \- Participants will not qualify for the current study if they do not meet the above inclusion criteria.

Contact & Investigator

Central Contact

Christopher J Brush, Ph.D.

✉ cjbrush@auburn.edu

📞 334-844-4483

Frequently Asked Questions

Who can join the NCT07130734 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, up to 40 Years, studying Depression - Major Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07130734 currently recruiting?

Yes, NCT07130734 is actively recruiting participants. Contact the research team at cjbrush@auburn.edu for enrollment information.

Where is the NCT07130734 trial being conducted?

This trial is being conducted at Auburn, United States.

Who is sponsoring the NCT07130734 clinical trial?

NCT07130734 is sponsored by Auburn University. The trial plans to enroll 50 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology